ABSTRACT
The presentation provides a comprehensive overview of the development and manufacturing processes of antibody-drug conjugates (ADCs). It covers key aspects such as ADC structure and function, market trends, and the challenges of ADC manufacturing. The presentation also highlights Sartorius' support in process development, including chemical compatibility, validation services, and customized solutions. Furthermore, the advantages of using disposable equipment for ADC processes will be discussed.
3:00 PM - 3:45 PM
Comprehensive Solutions to Optimize The ADC Development and Manufacturing Process
👤 Marc Jenke, Ph.D., Principal Scientist in Application and Testing, Sartorius
3:45 PM - 4:00 PM
Live Questions and Answers
Marc Jenke, Ph.D.
Principal Scientist in Application and Testing
Sartorius
Marc Jenke serves as Principal Scientist in Application and Testing at Sartorius, with over 18 years of experience in biopharmaceutical downstream processing. He specializes in product management and developing single-use solutions, especially for tangential flow filtration applications. Marc's expertise includes innovations in downstream processes for new modalities, focusing on bio-conjugate and ADC manufacturing processes. He holds a Ph.D. and possesses a robust
Share With Your Network
